Armstrong, E. J., Chen, D. C., Singh, G. D., Amsterdam, E. A., & Laird, J. R. (2015). Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Vascular medicine (London, England), 20(3), 237-244. https://doi.org/10.1177/1358863X15574321
Citace podle Chicago (17th ed.)Armstrong, Ehrin J., Debbie C. Chen, Gagan D. Singh, Ezra A. Amsterdam, a John R. Laird. "Angiotensin-converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Is Associated with Reduced Major Adverse Cardiovascular Events Among Patients with Critical Limb Ischemia." Vascular Medicine (London, England) 20, no. 3 (2015): 237-244. https://doi.org/10.1177/1358863X15574321.
Citace podle MLA (9th ed.)Armstrong, Ehrin J., et al. "Angiotensin-converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Is Associated with Reduced Major Adverse Cardiovascular Events Among Patients with Critical Limb Ischemia." Vascular Medicine (London, England), vol. 20, no. 3, 2015, pp. 237-244, https://doi.org/10.1177/1358863X15574321.